NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
11 trialsNCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT06006338 2023-09-21
3D Printed Models for Liver Surgery
Zhejiang Cancer Hospital
Phase 1 Unknown
NCT05738447 2023-02-22
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
West China Hospital
Phase 1 Unknown
NCT05240690 2022-02-15
Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies
Zhongnan Hospital
Phase 1 Unknown
NCT05123209 2021-11-17
Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1 Unknown
NCT03971747 2020-04-07
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
Phase 1 Unknown
NCT03993743 2019-08-28
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
Xijing Hospital
Phase 1 Unknown
NCT03674073 2018-10-18
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
Chinese PLA General Hospital
Phase 1 Unknown
NCT02650375 2017-01-23
Study of Metatinib Tromethamine Tablet
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT01721941 2014-07-04
TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma
Scripps Clinic Cancer Center
Phase 1 Unknown